MXCT US Equity
Maxcyte, Inc.Health Care · Services-Commercial Physical & Biological Research · CIK 1287098 · FY ends Dec 31$1.39
+0.12 (+9.45%)
USD · as of 2026-08-19 · marketstack
Short interest· FINRA consolidated · settlement 2026-07-31
6 settlement cycles| Shares short | 1.2M |
| % of shares out | 1.2% |
| Days to cover | 1.6 |
| Δ vs 2026-07-15 | -11.7% |
bars = shares short · line = days to cover (own scale)
| Settlement | Shares short | Δ vs prior | Avg daily volume | Days to cover |
|---|
| 2026-07-31 | 1,242,618 | -11.7% | 784,404 | 1.6 |
| 2026-07-15 | 1,406,444 | -7.2% | 1,151,692 | 1.2 |
| 2026-06-30 | 1,515,592 | -64.3% | 2,364,915 | 1.0 |
| 2026-06-15 | 4,239,514 | -5.2% | 734,485 | 5.8 |
| 2026-05-29 | 4,469,961 | -5.4% | 1,176,759 | 3.8 |
| 2026-05-15 | 4,724,376 | -9.9% | 1,254,248 | 3.8 |
FINRA Rule 4560 · twice monthly, published ~a week later.
Output of a disclosed model — assumptions may be wrong. Research, not investment advice. See the Disclaimer.
